Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiro Fukae

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Journal of the Peripheral Nervous System : JPNS|January 31, 2018
Clinical and genetic features of Charcot-Marie-Tooth disease 2F and hereditary motor neuropathy 2B in JapanHajime Tanabe, Yujiro Higuchi, Jun-Hui Yuan, et al.
BMC Neurology|March 4, 2022
Evaluating the impact of adjunctive istradefylline on the cumulative dose of levodopa-containing medications in Parkinson's disease: study protocol for the ISTRA ADJUST PD randomized, controlled studyTaku Hatano, Osamu Kano, Renpei Sengoku, et al.
Clinical Parkinsonism & Related Disorders|May 5, 2025
Impact of istradefylline on motor and non-motor symptoms in patients with Parkinson's disease: Subanalysis of the ISTRA ADJUST PDHiroshi Nagayama, Osamu Kano, Renpei Sengoku, et al.
Neurology and Therapy|January 16, 2024
Impact of Istradefylline on Levodopa Dose Escalation in Parkinson's Disease: ISTRA ADJUST PD Study, a Multicenter, Open-Label, Randomized, Parallel-Group Controlled StudyTaku Hatano, Renpei Sengoku, Hiroshi Nagayama, et al.
Movement Disorders Clinical Practice|January 24, 2024
Efficacy and Safety of Elobixibat in Parkinson's Disease with Chronic Constipation: CONST-PD StudyTaku Hatano, Genko Oyama, Yasushi Shimo, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Journal of the Peripheral Nervous System : JPNS|January 31, 2018
Clinical and genetic features of Charcot-Marie-Tooth disease 2F and hereditary motor neuropathy 2B in JapanHajime Tanabe, Yujiro Higuchi, Jun-Hui Yuan, et al.
BMC Neurology|March 4, 2022
Evaluating the impact of adjunctive istradefylline on the cumulative dose of levodopa-containing medications in Parkinson's disease: study protocol for the ISTRA ADJUST PD randomized, controlled studyTaku Hatano, Osamu Kano, Renpei Sengoku, et al.
Clinical Parkinsonism & Related Disorders|May 5, 2025
Impact of istradefylline on motor and non-motor symptoms in patients with Parkinson's disease: Subanalysis of the ISTRA ADJUST PDHiroshi Nagayama, Osamu Kano, Renpei Sengoku, et al.
Neurology and Therapy|January 16, 2024
Impact of Istradefylline on Levodopa Dose Escalation in Parkinson's Disease: ISTRA ADJUST PD Study, a Multicenter, Open-Label, Randomized, Parallel-Group Controlled StudyTaku Hatano, Renpei Sengoku, Hiroshi Nagayama, et al.
Movement Disorders Clinical Practice|January 24, 2024
Efficacy and Safety of Elobixibat in Parkinson's Disease with Chronic Constipation: CONST-PD StudyTaku Hatano, Genko Oyama, Yasushi Shimo, et al.
Pageof 7